Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Predicted Market Size Trajectory For The Gastrointestinal Pathogen Testing Market From 2025 To 2034?
The gastrointestinal pathogen testing market size has consistently expanded in recent years. This market is set to increase from $4.05 billion in 2024 to $4.23 billion in 2025, achieving a compound annual growth rate (CAGR) of 4.4%. The historical growth of this market can be attributed to several factors, including the rising occurrence of gastrointestinal infections, enhanced awareness regarding foodborne illnesses, globalization leading to an uptick in travel-related infections, regulatory measures for food safety, an increase in healthcare spending, and a greater demand for swift and precise diagnostic solutions.
The market size for gastrointestinal pathogen testing is projected to experience consistent expansion over the upcoming years. This market is anticipated to reach $4.92 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 3.9%. The observed growth during this forecast timeframe stems from several factors, including the global rise in gastrointestinal infections, greater understanding of the necessity for prompt diagnosis and intervention, the development of healthcare infrastructure in developing nations, an increasing need for point-of-care testing methods, strengthened emphasis on food safety rules, and ongoing innovation and development initiatives. Key trends predicted for the forecast period encompass accelerated testing methodologies, the increasing utilization of molecular diagnostic approaches, the spread of point-of-care testing into unconventional medical environments, progress in automation and robotics to optimize testing procedures, the discovery of new biomarkers for improved pathogen identification, and the incorporation of artificial intelligence and machine learning algorithms.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15571&type=smp
Which Drivers Are Supporting Growth Of The Gastrointestinal Pathogen Testing Market?
An anticipated factor driving the expansion of the gastrointestinal pathogen testing market is the increasing occurrence of foodborne diseases. These diseases are ailments resulting from the ingestion of food or drinks that have been tainted by harmful microorganisms, toxins, or chemical agents. Examples of foodborne diseases encompass listeriosis, viral gastroenteritis, taeniasis, and trichinosis. The increase in foodborne incidents stems from multiple causes, such as shifts in how food is produced, distributed, and consumed, insufficient food safety protocols, and the effects of climate change on agricultural output. Gastrointestinal testing assists in pinpointing the particular pathogens causing foodborne illnesses, thereby enabling healthcare professionals to ascertain the origin of gastrointestinal symptoms, prescribe suitable treatments, monitor outbreaks, and enact preventative steps to curb the transmission of these diseases. For example, data released in February 2024 by the UK Health Security Agency, a government organization in the UK, indicated that England and Wales recorded 167 cases of listeriosis in 2022, an increase from 160 cases reported in 2021. Consequently, the growing frequency of foodborne diseases is a significant catalyst for the expansion of the gastrointestinal pathogen testing market.
What Are The Primary Types Of Segments Analyzed In The Gastrointestinal Pathogen Testing Market?
The gastrointestinal pathogen testingmarket covered in this report is segmented –
1) By Pathogen Type: Bacteria; Viruses; Parasites
2) By Test Type: Molecular Tests; Culture; Biochemical Tests; Other Test Types
3) By Panel Type: Syndromic Full Multiplex Panels; Other Panel Types
4) By End-User: Hospitals; Diagnostic Laboratories; Point-Of-Care; Other End Users
Subsegments:
1) By Bacteria: Salmonella spp.; Escherichia coli; Campylobacter spp.; Shigella spp.; Clostridium difficile; Vibrio spp.; Listeria monocytogenes; Helicobacter pylori; Other Bacterial Pathogens
2) By Viruses: Norovirus; Rotavirus; Enteric Adenovirus; Hepatitis A Virus (HAV); Astrovirus; Other Viral Pathogens
3) By Parasites: Giardia lamblia; Entamoeba histolytica; Cryptosporidium spp.; Trichinella spp.; Toxoplasma gondii; Other Parasitic Pathogens
What Key Innovation Trends Are Fueling Advancements In The Gastrointestinal Pathogen Testing Market?
Companies operating within the gastrointestinal pathogen testing market are increasingly focused on creating advanced solutions, such as metagenomic diagnostic tests, to improve the precision, speed, and scope of identifying gastrointestinal pathogens. A metagenomic diagnostic test employs sophisticated technology to examine the genetic material of microorganisms found in samples like stool or blood. For example, in April 2024, Microba Life Sciences, an Australian biotechnology firm, launched MetaPanel, a metagenomic diagnostic test designed for highly accurate detection of a broad spectrum of gastrointestinal pathogens. MetaPanel identifies 175 pathogen targets in one test, providing healthcare professionals with a complete tool for diagnosing both common and challenging-to-detect infections. This test utilizes next-generation sequencing (NGS) technology to analyze diverse genetic material within a stool sample, enabling the identification of numerous potential pathogens, including those not typically covered by conventional GI panels.
Who Are The Prominent Global Companies Shaping The Gastrointestinal Pathogen Testing Market?
Major companies operating in the gastrointestinal pathogen testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Becton Dickinson and Company, Hologic Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Cepheid Inc., OraSure Technologies Inc., BioFire Diagnostics Inc., Luminex Corporation, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ELITechGroup S.A.S., Hardy Diagnostics LLC, Trinity Biotech plc, Puritan Medical Products Co. LLC, Cosmo Bio Co. Ltd., R-Biopharm AG, COPAN Diagnostics Inc., Savyon Diagnostics Ltd., ZeptoMetrix Corporation, Biomerica Inc., Pro-Lab Diagnostics
Download The Full Report For Exclusive Market Findings:
Which Region Is Projected To Lead The Gastrointestinal Pathogen Testing Market During The Forecast Period?
North America was the largest region in the gastrointestinal pathogen testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Gastrointestinal Pathogen Testing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15571&type=smp
Browse Through More Reports Similar to the Global Gastrointestinal Pathogen Testing Market 2025, By The Business Research Company
Gastrointestinal Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report
Gastrointestinal Bleeding Treatment Devices Global Market Report 2025
Food Pathogen Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/food-pathogen-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model